GLP1R and congestive heart failure: The magnitude of the benefit of GLP1R agonists on MACE was attenuated in patients with a younger age, with a body mass index less than 30, with a history of congestive heart failure (Additional file 3: Figure S5), but the tests for interaction were not significant (Table 2).